Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacogenetic study of abiraterone acetate in castration-resistant prostate cancer
2012-005036-28Phase 4Completed
- Sponsor
- Centre Antoine Lacassagne
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of abiraterone in prostate cancer (PCa), sponsored by Centre Antoine Lacassagne. Primary endpoint: Progression-free survival. Started Apr 2013; status: completed.
02
Drugs
abiraterone
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on 2012-005036-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005036-28.